Ophthalmic Eye Dropper Market Outlook Report 2024-2033: Trends, Analysis, Insights, and Overview
Global ophthalmic eye dropper market size is expected to reach $17.97 Bn by 2028 at a rate of 7.8%, segmented as by eye dropper, unidose eye dropper, preserved multi-dose eye dropper, preservative-free multi-dose eye dropper
bhuvan tbrc Share this Post to earn Money ( Upto ₹100 per 1000 Views )
An ophthalmic eye dropper is a medical device specifically designed for administering liquid medication, typically in the form of eye drops, into the eyes. The ophthalmic eye dropper is used by gently squeezing the bottle to release a drop into the lower eyelid pocket, ensuring precise administration of medication into the eye.
Sizing and Forecast
The ophthalmic eye dropper market size has grown strongly in recent years. It will grow from $12.38 billion in 2023 to $13.32 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to enhanced patient convenience, favorable regulatory environment, adoption of combination therapies, shift towards combination therapies, and preference for self-administered eye care products.
The ophthalmic eye dropper market size is expected to see strong growth in the next few years. It will grow to $17.97 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to the rising prevalence of eye-related conditions, public health initiatives, increasing use of precision and individualized medicines, consumer education initiatives, and research and development. Major trends in the forecast period include nanoparticle-based drug formulations, advanced drug delivery systems, emphasis on innovative drug delivery, collaborative efforts for innovative solutions, and a surge in demand for multi-dose eye droppers.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/ophthalmic-eye-dropper-global-market-report
Segmentation & Regional Insights
The ophthalmic eye dropper market covered in this report is segmented –
1) By Eye Dropper: Unidose Eye Dropper, Preserved Multi-Dose Eye Dropper, Preservative-Free Multi-Dose Eye Dropper
2) By Drug Type: Prescription Drugs, Over-The-Counter (OTC) Drugs
3) By Treatment Type: Dry Eye, Glaucoma, Allergies, Conjunctivitis, Other Treatment Type
4) By End-Use: Hospitals, Ophthalmic Centers, Homecare Settings, Other End-Users
North America was the largest region in the ophthalmic eye dropper market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic eye dropper market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15878&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of eye disorders is expected to propel the growth of the ophthalmic eye dropper market going forward. Eye disorders refer to a broad spectrum of medical conditions that affect the eyes, impairing vision or causing discomfort. The increasing prevalence of eye disorders is due to environmental factors, increased use of contact lenses, lifestyle changes, gender differences, and vitamin deficiencies. Ophthalmic eye droppers are used to administer precise doses of medication directly to the eyes to treat various eye disorders. For instance, in January 2024, according to the Centers for Disease Control and Prevention, a US-based science and data-driven service organization that protects the public's health, over 3.4 million Americans aged 40 years and older were blind or visually impaired, which is expected to double by 2030. Therefore, the increasing prevalence of eye disorders is driving the growth of the ophthalmic eye dropper market.
Key Industry Players
Major companies operating in the ophthalmic eye dropper market are Pfizer Inc., AbbVie Inc., Novartis AG, Alcon Inc., Bausch & Lomb Incorporated, Rexam Healthcare Packaging Inc., Intas Pharmaceuticals Ltd., AptarGroup Inc, Cipla Ltd, Gerresheimer AG, Lupin Ltd., Santen Pharmaceutical Co Ltd., Rohto Pharmaceutical Co Ltd., Silgan Dispensing Systems, Akorn Operating Company LLC, Nemera Development S.A., Ajanta Pharma Ltd., Perrigo Company plc, Bora Pharmaceuticals Co Ltd., Sun Pharmaceutical Industries Limited, Flagship Biotech International Private Limited, PanOptica Inc., SAS Yslab
The ophthalmic eye dropper market report table of contents includes:
- Executive Summary
- Market Characteristics
- Market Trends And Strategies
- Impact Of COVID-19
- Market Size And Growth
- Segmentation
- Regional And Country Analysis
.
.
.
- Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
